Market Place
Sourcing Support
Biocodex Strengthens Supply Chain Resilience with Kinaxis
16 Dec 2024 //
BUSINESSWIRE
Resilience is cutting 105 jobs at a production plant in Florida
06 Dec 2024 //
FIERCE PHARMA
Resilience Appoints William S. Marth as CEO
05 Dec 2024 //
BUSINESSWIRE
Piramal Pharma Releases FY 2023-24 Sustainability Report
04 Oct 2024 //
PR NEWSWIRE
Resilience Funded To Expand US Pharma Ingredient Production
03 Oct 2024 //
BUSINESSWIRE
Resilience Enhances Clinical And Commercial Drug Product Mfg Capabilities
20 Feb 2024 //
PRESS RELEASE
Resilience Expands Drug Product Manufacturing Capabilities
20 Feb 2024 //
BUSINESSWIRE
Resilience Partners With Taiwan Bio-Mfg Corp For Biomanufacturing Innovation
01 Feb 2024 //
PRESS RELEASE
VGXI Announces Strategic Multi-Year Partnership with Resilience
24 Jan 2024 //
PR NEWSWIRE
Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
PRESS RELEASE
Scoop: Resilience receives Form 483 due to mold at Canadian site
04 Jan 2024 //
ENDPTS
Scoop: Resilience downsizes technical R&D and quality assurance divisions
20 Dec 2023 //
ENDPTS
Resilience building out Ohio facility, adding 440 jobs
12 Dec 2023 //
FIERCE PHARMA
Resilience Appoints Bill Marth as President of Services
07 Nov 2023 //
BUSINESSWIRE
BridgeBio and Resilience Announce Strategic Multi-Year Partnership
03 Oct 2023 //
BUSINESSWIRE
Resilience, Lifera to Develop Manufacturing Facility in Saudi Arabia
01 Sep 2023 //
CONTRACT PHARMA
Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908
26 Apr 2023 //
BUSINESSWIRE
Resilience notches $410M in federal financing to bolster production
27 Mar 2023 //
ENDPTS
Resilience Approved for $410M Financing from the Department of Defense
24 Mar 2023 //
BUSINESSWIRE
Resilience inks 3rd sale-leaseback deal with Oxford Properties
21 Feb 2023 //
FIERCE PHARMA
Resilience Signs Biomanufacturing Partnership with Pharmaceutical Company
16 Feb 2023 //
BUSINESSWIRE
Resilience to Build New Biopharma Manufacturing Facility in the UAE
13 Jan 2023 //
CONTRACT PHARMA
Resilience Announces Equity Investment from Mubadala
10 Jan 2023 //
BUSINESSWIRE
AZ sells US plant to Resilience, forging manufacturing pact in the process
30 Nov 2022 //
FIERCEPHARMA
Resilience partners with the California Institute for Regenerative Medicine
24 Aug 2022 //
ENDPTS
Resilience Becomes Biomanufacturing Resource Partner for California Institute
23 Aug 2022 //
BUSINESSWIRE
Resilience Announces Collaboration to Manufacture and Deliver Biotherapeutics
15 Aug 2022 //
BUSINESSWIRE
Resilience collaborates with the Mayo Clinic
15 Aug 2022 //
ENDPTS
A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders
30 Jun 2022 //
ENDPTS
ARCH-backed Resilience nabs $625M in Series D financing round
06 Jun 2022 //
ENDPTS
Resilience forges JV with MD Anderson, readying new cell therapies for cancer
06 Jun 2022 //
ENDPTS
Resilience Announces $625M Series D Financing
06 Jun 2022 //
BUSINESSWIRE
Resilience inks manufacturing pact with ARCH-backed cell therapy startup
19 May 2022 //
ENDPTS
Opus Enters Strategic Collaboration with Resilience for AAV-based Gene Therapy
11 Apr 2022 //
GLOBENEWSWIRE
ADDING MULTIMEDIA Capri EGM Acquires R&D Build-to-Suit for National Resilience
24 Feb 2022 //
BUSINESSWIRE
Resilience moves Canadian site into plasma therapies, after deal with Takeda
18 Feb 2022 //
ENDPTS
Resilience teams with Takeda on plasma-based therapy production
15 Feb 2022 //
FIERCEPHARMA
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250M
09 Feb 2022 //
BUSINESSWIRE
Resilience Acquires SwiftScale Biologics
02 Dec 2021 //
BUSINESSWIRE
Cellevolve Launches with Acclaimed Investors & Pivotal Manufacturing Partnership
18 Nov 2021 //
BUSINESSWIRE
Resilience and Harvard University Announce 5 Year R&D Alliance, Launch Companies
15 Oct 2021 //
BUSINESSWIRE
Resilience to Manufacture mRNA for Moderna`s COVID-19 Vaccine
09 Sep 2021 //
FIERCEPHARMA
Resilience shells out $110M for bluebird bio site, kickstarting new collaboration
30 Jul 2021 //
ENDPTS
